Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind trial of octenidine + prednicarbate cream versus mono-substances in inflammatory tinea pedis
2009-016626-14Phase 2Completed
- Sponsor
- Almirall
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Athlete's foot comparing LAS 41003 (octenidine + prednicarbate) cream, Octenidine cream and Prednicarbate cream (3 arms). Primary endpoint: Treatment success. Started Nov 2009; status: completed.
02
Drugs
Momefusidoctenidineprednicarbate
03
Conditions
Athlete's foot
Beyond the preview
Go deeper on 2009-016626-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016626-14.